Chong Kun Dang Pharmaceutical Corp. (185750.KS) KSC

Currency In KRW

AD

Valuation

Market Cap1.09T
Enterprise Value1.24T
P/E Ratio11.42
PEG Ratio-0.67
Price/Sales Ratio0.52
Price/Book Ratio0.92
Enterprise/Revenue0.63
Enterprise/EBITDA8.45

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.05
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue1.69T
Revenue/Share125,997.47
Gross Profit517.23B
EBITDA125.37B
Net Income77.83B
Diluted EPS5,845.54

Balance Sheet

Total Cash285.23B
Total Cash/Share20,664.08
Total Debt368B
Total Debt/Equity0.36
Current Ratio2
Book Value Per Share74,533.06

Price History

52-Week Change-16.65
52-Week High106,800
52-Week Low67,200
Moving Average 50 Days80,772
Moving Average 200 Days84,419

Statistics

Average Volume31,169
Shares Outstanding13.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate500
Trailing Annual Dividend Yield0.73
Payout Ratio0.18
Last Split Factor21:20
Last Split DateDecember 27, 2024
AD